Rare diseases
Investigational molecules
Locations
Back to Hungary110 clinical trials in Gyongyos, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
HungaryStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
HungaryStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
HungaryStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
HungaryStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
HungaryStudy on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer
HungaryLong-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment
HungaryStudy on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease
HungaryStudy on Long-Term Safety of Etrasimod Arginine for Patients with Moderately to Severely Active Ulcerative Colitis
HungaryStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
HungaryStudy Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
HungaryStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for non-small cell lung cancer (NSCLC) and chronic respiratory conditions, with multiple trials evaluating new immunotherapy combinations and targeted therapies.
Several trials are exploring combination therapies to improve patient outcomes in advanced stages of lung cancer.
Comprehensive studies on inflammatory and autoimmune disorders, including psoriasis and inflammatory bowel diseases, testing novel therapeutic approaches.
Multiple trials are evaluating new biological therapies for moderate to severe cases of these conditions.
Innovative studies targeting heart failure prevention and cardiovascular disease management, with a focus on reducing major adverse cardiac events.
Research includes novel therapeutic combinations and preventive strategies for high-risk patients.
Clinical research focusing on Alzheimer's Disease and associated conditions, particularly investigating treatments for psychosis symptoms.
Trials are evaluating new therapeutic approaches for managing neuropsychiatric symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
